Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

RadNet, Inc. - Common Stock (NQ:RDNT)

48.70 -0.81 (-1.64%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about RadNet, Inc. - Common Stock

< Previous 1 2 3 Next >
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including NeoGenomics (NASDAQ:NEO) and its peers. 
Via StockStory
Q4 Earnings Outperformers: AMN Healthcare Services (NYSE:AMN) And The Rest Of The Healthcare Providers & Services Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including AMN Healthcare Services... 
Via StockStory
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack
Looking back on testing & diagnostics services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Labcorp (NYSE:LH) and its peers. 
Via StockStory
Forecasting The Future: 4 Analyst Projections For RadNet
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
Breaking Down RadNet: 5 Analysts Share Their Views
Via Benzinga
Analyst Scoreboard: 4 Ratings For RadNet
Via Benzinga
RadNet (RDNT): Buy, Sell, or Hold Post Q4 Earnings?
RadNet has gotten torched over the last six months - since September 2024, its stock price has dropped 25.7% to $51.34 per share. This may have investors wondering how to approach the situation. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q4, starting... 
Via StockStory
What 5 Analyst Ratings Have To Say About RadNet
Via Benzinga
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Quest (NYSE:DGX) and the best and worst... 
Via StockStory
P/E Ratio Insights for RadNet
Via Benzinga
Unveiling 7 Analyst Insights On RadNet
Via Benzinga
Peeling Back The Layers: Exploring RadNet Through Analyst Insights
Via Benzinga
Top 3 Health Care Stocks You'll Regret Missing This Quarter
Via Benzinga
RadNet’s (NASDAQ:RDNT) Q4 Sales Top Estimates But Stock Drops
Diagnostic imaging company RadNet (NASDAQ:RDNT) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 13.5% year on year to $477.1 million. On the other hand, the... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
What To Expect From RadNet’s (RDNT) Q4 Earnings
Diagnostic imaging company RadNet (NASDAQ:RDNT) will be reporting results tomorrow after market hours. Here’s what to look for. 
Via StockStory
Jim Cramer: This Industrial Stock Is 'Absolutely Terrific', First Solar Is 'Very Inexpensive'
First Solar will report financial results for the fourth quarter and full year ended Dec. 31, 2024, after the closing bell on Tuesday, Feb. 25, 2025. 
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For RadNet
Via Benzinga
Expert Ratings For RadNet
Via Benzinga
Peeling Back The Layers: Exploring RadNet Through Analyst Insights
Via Benzinga
RDNT Stock Earnings: RadNet Beats Revenue for Q1 2024
RDNT stock results show that RadNet beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Top 3 Health Care Stocks That Could Blast Off This Quarter
Via Benzinga
DaVita Stock Sees Improved Relative Strength Rating
DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
Via Benzinga
GE HealthCare And DeepHealth Team Up To Advance AI-Powered Breast Cancer Screening: Details
GE HealthCare and DeepHealth collaborate to develop AI-powered solutions for imaging, starting with breast cancer screening. 
Via Benzinga
What 4 Analyst Ratings Have To Say About RadNet
Via Benzinga
Imaging Centers Operator RadNet Q3 Earnings: Strong Q3 Performance On Positive Trends, Raises Annual Outlook
RadNet posted Q3 2024 revenue of $461.1 million, beating estimates. Digital Health revenue rose 34.3%, driving growth in AI mammography. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cramer Calls Datadog 'Dynamite,' Puts SoFi In Dog House: 'What The Heck Is Going On'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Marvell Technology, Inc. (NASDAQ: MRVL) reported a mixed quarter. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.